Trident Lifeline Limited
Bookbuilding IPO · BSE
- Price band
- ₹101 - ₹101
- Lot size
- 1,200 shares
- Issue amount
- ₹35.34 cr
- Total subscription
- 1.34×
- Opens
- 26 Sept 2022
- Closes
- 29 Sept 2022
- Allotment
- 4 Oct 2022
- Listing
- 10 Oct 2022
Offer at a glance
Issue overview
- Issue size
- 34,99,200 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,21,200
- Fresh issue
- ₹35.34 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- BSE
- Maximum investment
- ₹1,21,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 80,00,000
- Shares after issue
- 1,14,99,200
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,21,200 |
| HNI | 2 | 2,400 | ₹2,42,400 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Promoters
Mr. Hardik Jigishkumar Desai
Mr. Mayurkumar Mansukhbhai Gajera
Mrs. Rupaben C Jariwala
Mrs. Rinkal Mayurbhai Gajera
Mr. Tarang Nathabhai Gajera
Mr. Mohak Nathabhai Gajera
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
2nd Floor, Shop-2004, North Extension, Falsawadi Begumpura, Nodh-4/1650, Sahara Darwaja, Surat – 395003
8160276395
[email protected]Company website ↗Frequently Asked Questions
What is Trident Lifeline IPO GMP today?
As of today, Trident Lifeline IPO Grey Market Premium (GMP) is reported at +₹2 per share. Based on the upper price band of ₹101, the estimated listing price is ₹103 (+2.0% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Trident Lifeline IPO?
The minimum bid lot size for Trident Lifeline IPO is 1,200 shares. At the cut-off price of ₹101 per share, retail investors need a minimum application amount of ₹1,21,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Trident Lifeline IPO allotment status be announced?
The allotment status for Trident Lifeline IPO is scheduled to be finalized on 4 Oct 2022. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Trident Lifeline IPO allotment status online by PAN?
To check Trident Lifeline IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Trident Lifeline Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.